Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin.

A. R. Thierry, T. J. Jorgensen, D. Forst, J. A. Belli, A. Dritschilo, A. Rahman

Research output: Contribution to journalArticle

Abstract

A Chinese hamster cell line (LZ), selected for multidrug resistance (MDR), exhibits a 3,000-fold resistance to doxorubicin, compared to parental V-79 cells. These drug resistant cells have amplified MDR genes, overexpress P-glycoprotein, and in the presence of doxorubicin show reduced intracellular drug accumulation. Using liposome-encapsulated doxorubicin (Rahman et al. Cancer Res. 45:796-803; 1985), we observed partial reversal of the resistance of LZ cells to this drug and a higher intracellular drug accumulation, compared to free drug. Parental V-79 cells, however, did not exhibit differences in survival or in drug accumulation when treated with encapsulated or free doxorubicin. Comparison of the effect of liposome-encapsulated doxorubicin with that of verapamil in reversing drug resistance showed that the liposomal preparation was as effective as verapamil used at its maximum clinically relevant concentration (1.5 microM). These results suggest that the use of liposomes as carriers of anticancer drugs may offer a strategy for overcoming MDR in tumor cells.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalCancer communications
Volume1
Issue number5
StatePublished - 1989

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin.'. Together they form a unique fingerprint.

  • Cite this

    Thierry, A. R., Jorgensen, T. J., Forst, D., Belli, J. A., Dritschilo, A., & Rahman, A. (1989). Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin. Cancer communications, 1(5), 311-316.